Sallie Permar, M.D., Ph.D.
< Back to Search Results

Sallie Permar, M.D., Ph.D.


Profile Photo of Sallie Permar, M.D., Ph.D.
Not Accepting New Patients
Gender: Female
Language: English


Personal Statement

I am passionate about giving children the best possible start to a full and healthy life. As chair and pediatrician-in-chief, I am committed to bringing the engines of medical care, research, and education closer together—translating our findings from the lab to the clinic, and teaching the next generation of physicians and pediatrician-scientists.

Specialties and Expertise


  • Pediatric Infectious Disease


  • CMV Infection
  • HIV
  • Cytomegalovirus (CMV) Infection


Sallie Permar, M.D., Ph.D is an eminent physician-scientist who focuses on the treatment and prevention of neonatal viral infections. She serves as Chair of the Department of Pediatrics at Weill Cornell Medicine and Pediatrician-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center and NYP Komansky Children’s Hospital.  She is also the Nancy C. Paduano Professor in Pediatrics at Weill Cornell Medicine and Professor of Immunology and Microbial Pathogenesis at the Weill Cornell Graduate School.

A prominent physician-scientist focusing on the prevention and treatment of neonatal viral infections, Dr. Permar leads a research laboratory investigating immune protection against vertical transmission of neonatal viral pathogens, namely HIV and cytomegalovirus (CMV).  She has made important contributions to the development of vaccines for prevention of vertical HIV transmission, defining both innate and adaptive immune responses that are associated with protection against infant HIV acquisition.  Moreover, Dr. Permar is leading the development of HIV vaccine strategies in preclinical maternal/infant nonhuman primate models and translation of this work for clinical vaccine trials in infants. Dr. Permar has also defined determinants of congenital and perinatal CMV transmission, developing the first nonhuman primate model of congenital CMV infection and leading human cohort studies that have defined immune correlates of protection necessary to guide vaccine development. 

Dr. Permar has published nearly 150 studies in journals including Nature Medicine, Cell, Proceedings of the National Academy of Sciences and JAMA Pediatrics, as well as top publications in her field, and her work has been consistently funded by the National Institutes of Health (NIH) and foundations such as the Bill and Melinda Gates Foundation and the Doris Duke Charitable Foundation. She serves on the editorial board for the Journal of Clinical Investigation and the Journal of Virology.

She has led a number of NIH-funded training programs to develop physician-scientists, including serving as director of the Pediatric Scientist Development Program, which is supported by the National Institute of Child Health and Development (NICHD) and the Association of Medical School Pediatric Department Chairs (AMSPDC), and which trains pediatric subspecialists across the nation for a career in pediatric health research.

Dr. Permar has a PhD in Microbiology/Immunology from Johns Hopkins Bloomberg School of Public Health in Baltimore, an M.D. from Harvard Medical School and completed her clinical training in pediatric infectious diseases at Children’s Hospital in Boston. She has received several prestigious investigator awards, including the Presidential Early Career Award in Science and Engineering (PECASE), the E. Mead Johnson Award from the Society of Pediatric Research, and was inducted into the American Society of Clinical Investigation (ASCI) and is a Fellow of the American Academy of Microbiology (AAM) and the American Association of Advancement of Science.  In 2020, she received the Oswald Avery Award for Early Achievement from the Infectious Diseases Society of America.  Dr. Permar also serves on the board of the National CMV Foundation. She is an institutional and national leader in physician-scientist training, serving as the Director of the National Institute of Child Health and Development (NICHD) Pediatric Scientist Development Program.



Board Certifications

  • American Board of Pediatrics
  • American Board of Pediatrics (Pediatric Infectious Diseases)

Clinical and Academic Positions

  • Pediatrician-in-Chief - NewYork-Presbyterian Hospital
  • Chair of Pediatrics - Weill Cornell Medical College, Cornell University
  • Nancy C. Paduano Professor in Pediatrics - Weill Cornell Medical College, Cornell University
  • Professor of Pediatrics - Weill Cornell Medical College, Cornell University

Education and Training

  • M.D., Harvard Medical School, 2004
  • Ph.D., The Johns Hopkins University, 2004
  • B.S., Davidson College, 1997


Insurance Plans Accepted

The following represents most of the managed care plans accepted by this doctor. If your insurance carrier does not appear here please contact the doctor’s office as they may have individual contracts not included on this site.

* indicates this doctor is no longer accepting new patients with this insurance plan.

  • AETNA - Medicare
  • Aetna - Weill Cornell - POS
  • Aetna-NYP - EPO/POS
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield - Blue Access
  • Empire Blue Cross/Blue Shield - EPO
  • Empire Blue Cross/Blue Shield - HMO
  • Empire Blue Cross/Blue Shield - Mediblue (Senior)
  • Empire Blue Cross/Blue Shield - PPO
  • Empire Blue Cross/Blue Shield HealthPlus
  • Empire Blue Cross/Blue Shield HealthPlus - CHP
  • Fidelis Care
  • GHI - CBP
  • Health First
  • Health Insurance Plan of NY (HIP)
  • Health Insurance Plan of NY (HIP) - Medicaid
  • Medicaid
  • Medicare
  • Oxford Health Plans - Freedom
  • Oxford Health Plans - Liberty
  • Oxford Health Plans - Metro/Core/Charter
  • Rockefeller University - Trustmark
  • United Empire
  • United Healthcare
  • United Healthcare - Community Plan
  • United Healthcare Compass
  • WorldWide Medical

Locations and Appointments

External Relationships

External Relationships

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Dynavax Technologies; GlaxoSmithKline; HOOKIPA Pharma Inc.; Merck & Co., Inc.; ModernaTX; Pfizer, Inc.